
3.27 Delayed Data As of Sep 29 | ![]() Today’s Change | 2.90 Today|||52-Week Range 6.45 | -23.06% Year-to-Date |
ANIXA BIOSCIENCES INC (ANIX) Upgraded to Buy: What Does It Mean for the Stock? Sep 21 / Zacks.com - Paid Partner Content |
Previous close | 3.21 |
Today’s open | 3.22 |
Day’s range | 3.22 - 3.27 |
Volume | 606 |
Average volume (3 months) | 70,601 |
Market cap | $111.2M |
Earnings growth (last year) | +1.26% |
Earnings growth (this year) | -- |
Earnings growth (next 5 years) | -- |
Revenue growth (last year) | -100.00% |
P/E ratio | NM |
Price/Sales | -- |
Price/Book | 3.81 |
Last reporting date | September 29, 2023 |
EPS forecast (this quarter) | -$0.09 |
Annual revenue (last year) | $0.00 |
Annual profit (last year) | -$13.6M |
Net profit margin | -- |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Jose, California |